Can 3T multiparametric magnetic resonance imaging accurately detect prostate cancer extracapsular extension?

Journal of the Canadian Urological Association

Volumn 7, Issue 11-12, 2013, Pages

  Cerantola, Yannick ^a   Valerio, Massimo ^a   Kawkabani Marchini, Aida ^a   Meuwly, Jean Yves ^a   Jichlinski, Patrice ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84887337887     PISSN: 19116470     EISSN: None     Source Type: Journal    
DOI: 10.5489/cuaj.245     Document Type: Article

References (25)

1. Wolf AM, Wender RC, Etzioni RB, et al. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin 2010;60:70-98. http://dx.doi.org/10.3322/caac.20066
2. Freedland SJ. Screening, risk assessment, and the approach to therapy in patients with prostate cancer. Cancer 2011;117:1123-35. http://dx.doi.org/10.1002/cncr.25477
3. Sokoloff MH, Brendler CB. Indications and contraindications for nerve-sparing radical prostatectomy. Urol Clin North Am 2001;28:535-43. http://dx.doi.org/10.1016/S0094-0143(05)70161-0
4. Heidenreich A, Bellmunt J, Bolla M, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 2011;59:61-71. http://dx.doi.org/10.1016/j. eururo.2010.10.039
5. Han M, Partin AW, Piantadosi S, et al. Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. J Urol 2001;166:416-9. http://dx.doi.org/10.1016/ S0022-5347(05)65955-1
6. Cooperberg MR, Lubeck DP, Mehta SS, et al. Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE). J Urol 2003;170:S21-5; discussion S26-7.
7. Brajtbord JS, Lavery HJ, Nabizada-Pace F, et al. Endorectal magnetic resonance imaging has limited clinical ability to preoperatively predict pT3 prostate cancer. BJU Int 2011;107:1419-24. http://dx.doi. org/10.1111/j.1464-410X.2010.09599.x
8. Greene KL, Albertsen PC, Babaian RJ, et al. Prostate specific antigen best practice statement: 2009 update. J Urol 2009;182:2232-41. http://dx.doi.org/10.1016/j.juro.2009.07.093
9. Sciarra A, Barentsz J, Bjartell A, et al. Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. Eur Urol 2011;59:962-77. http://dx.doi.org/10.1016/j. eururo.2011.02.034
10. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 2003;326:41-4.
11. Tamada T, Sone T, Jo Y, et al. Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. Radiology 2008;248:531-9. http://dx.doi.org/10.1148/ radiol.2482070157
12. Walsh PC. Anatomic radical prostatectomy: evolution of the surgical technique. J Urol 1998;160:2418-24. http://dx.doi.org/10.1016/S0022-5347(01)62202-X
13. Nakashima J, Tanimoto A, Imai Y, et al. Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer. Urology 2004;64:101-5. http://dx.doi.org/10.1016/j.urology. 2004.02.036
14. Nepple KG, Rosevear HM, Stolpen AH, et al. Concordance of preoperative prostate endorectal MRI with subsequent prostatectomy specimen in high-risk prostate cancer patients. Urol Oncol 2013;31:601-6. http://dx.doi.org/10.1016/j.urolonc.2011.05.004. Epub 2011 Jun 12.
15. Kurhanewicz J, Vigneron D, Carroll P, et al. Multiparametric magnetic resonance imaging in prostate cancer: present and future. Curr Opin Urol 2008;18:71-7. http://dx.doi.org/10.1097/ MOU.0b013e3282f19d01
16. Dickinson L, Ahmed HU, Allen C, et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol 2011;59:477-94. http://dx.doi.org/10.1016/j.eururo.2010.12.009
17. Ohori M, Kattan MW, Koh H, et al. Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer. J Urol 2004;171:1844-9; discussion 1849.
18. Labanaris AP, Zugor V, Takriti S, et al. The role of conventional and functional endorectal magnetic resonance imaging in the decision of whether to preserve or resect the neurovascular bundles during radical retropubic prostatectomy. Scand J Urol Nephrol 2009;43:25-31. http://dx.doi. org/10.1080/00365590802326610
19. Zhang J, Hricak H, Shukla-Dave A, et al. Clinical stage T1c prostate cancer: evaluation with endorectal MR imaging and MR spectroscopic imaging. Radiology 2009;253:425-34. http://dx.doi.org/10.1148/ radiol.2532081390
20. Epstein JI, Carmichael MJ, Pizov G, et al. Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup. J Urol 1993;150:135-41.
21. Cornud F, Flam T, Chauveinc L, et al. Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results. Radiology 2002;224:203-10. http://dx.doi.org/10.1148/radiol.2241011001
22. Ikonen S, Kivisaari L, Vehmas T, et al. Optimal timing of post-biopsy MR imaging of the prostate. Acta Radiol 2001;42:70-3.
23. Park KK, Lee SH, Lim BJ, et al. The effects of the period between biopsy and diffusion-weighted magnetic resonance imaging on cancer staging in localized prostate cancer. BJU Int 2010;106:1148-51. http:// dx.doi.org/10.1111/j.1464-410X.2010.09287.x
24. Dickinson L, Ahmed HU, Moore C, et al. The effects of the time period between biopsy and diffusion-weighted magnetic resonance imaging on cancer staging in localized prostate cancer. BJU Int 2010;106:131-2; author reply 132. http://dx.doi.org/10.1111/j.1464-410X.2010.09451_1.x
25. Ikonen S, Kivisaari L, Vehmas T, et al. Optimal timing of post-biopsy MR imaging of the prostate. Acta Radiol 2001;42:70-3.